Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian longitudinal study of adult health (ELSA-Brasil);Acurácia diagnóstica de um escore de ultrassonografia hepática não invasivo para doença hepática gordurosa não alcoólica (DHGNA) no Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil)

Sao Paulo Medical Journal

Volumn 133, Issue 2, 2015, Pages 115-124

  Goulart, Alessandra Carvalho ^a   de Oliveira, Ilka Regina Souza ^a   Alencar, Airlane Pereira ^a   dos Santos, Maira Solange Camara ^a   Santos, Itamar Souza ^a   Martines, Brenda Margatho Ramos ^a   Meireles, Danilo Peron ^a   dos Martines, João Augusto Santos ^a   Misciagna, Giovanni ^b   Benseñor, Isabela Martins ^a   Lotufo, Paulo Andrade ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Diagnostic techniques and procedures; Epidemiology; Liver disease; Tomography; Ultrasonography; X ray computed

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; ARTICLE; ATTENUATION; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; WAIST CIRCUMFERENCE; AGED; BLOOD; BRAZIL; COMPLICATION; EVALUATION STUDY; LONGITUDINAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BODY MASS INDEX; BRAZIL; CHOLESTEROL; DIABETES COMPLICATIONS; FATTY LIVER; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON-ALCOHOLIC FATTY LIVER DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WAIST CIRCUMFERENCE;

EID: 84929688378     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-3180.2014.9150812     Document Type: Article

References (48)

1. Sanyal AJ, American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705-25.
2. Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005;42(2):473-80.
3. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and metabolic syndrome. Hepatology. 2003;37(4):917-23.
4. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450-5.
5. Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010;51(6):1979-87.
6. Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 2007;30(8):2119-21.
7. Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13(10):1579-84.
8. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341-50.
9. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124-31.
10. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292(6512):13-5.
11. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617-49.
12. Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol. 2010;52(4):579-85.
13. Chiloiro M, Riezzo G, Chiarappa S, et al. Relationship among fatty liver, adipose tissue distribution and metabolic profile in moderately obese children: an ultrasonographic study. Curr Pharm Des. 2008;14(26):2693-8.
14. Chiloiro M, Caruso MG, Cisternino AM, et al. Ultrasound evaluation and correlates of fatty liver disease: a population study in a Mediterranean area. Metab Syndr Relat Disord. 2013;11(5):349-58.
15. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082-90.
16. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745-50.
17. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis. 2008;28(4):386-95.
18. Zelber-Sagi S, Webb M, Assy N, et al. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J Gastroenterol. 2013;19(1):57-64.
19. Borges VF, Diniz AL, Cotrim HP, Rocha HL, Andrade NB. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound. 2013;41(1):18-25.
20. von Volkmann HL, Havre RF, Løberg EM, et al. Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease. Med Ultrason. 2013;15(1):16-22.
21. Webb M, Yeshua H, Zelber-Sagi S, et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol. 2009;192(4):909-14.
22. Marshall RH, Eissa M, Bluth EI, Gulotta PM, Davis NK. Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. AJR Am J Roentgenol. 2012;199(5):997-1002.
23. Haring R, Wallaschofski H, Nauck M, et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl-transpeptidase levels. Hepatology. 2009;50(5):1403-11.
24. Perez NE, Siddiqui FA, Mutchnick MG, et al. Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol. 2007;41(6):624-9.
25. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
26. Matsuoka MW, Oliveira IRS, Widman A, et al. Contribuição da ultrassonografia para o diagnóstico das alterações histopatológicas presentes na hepatite C crônica, com ênfase na esteatose hepática: Parte I [Contribution of ultrasonography to the diagnosis of chronic hepatitis C histopathological changes, with emphasis on hepatic steatosis: Part I]. Radiol Bras. 2011;44(3):141-6.
27. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology. 2002;36(5 Suppl 1):S57-64.
28. Lu ZF, Zagzebski JA, Lee FT. Ultrasound backscatter and attenuation in human liver with diffuse disease. Ultrasound Med Biol. 1999;25(7):1047-54.
29. Gaitini D, Baruch Y, Ghersin E, et al. Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter. Ultrasound Med Biol. 2004;30(10):1321-7.
30. Needleman L, Kurtz AB, Rifkin MD, et al. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol. 1986;146(5):1011-5.
31. Lupsor M, Badea R. Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy? Rom J Gastroenterol. 2005;14(4):419-25.
32. Aquino EM, Barreto SM, Bensenor IM, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol. 2012;175(4):315-24.
33. Lotufo PA. Construção do estudo longitudinal de saúde do adulto (ELSA-Brasil) [Setting up the Longitudinal Study for Adult Health (ELSA-Brasil)]. Rev Saude Publica. 2013;47 Suppl 2:3-9.
34. Fedeli LG, Vidigal PG, Leite CM, et al. Logística de coleta e transporte de materiaç biológico e organização do laboratório central no ELSA-Brasil [Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil]. Rev Saude Publica. 2013;47 Suppl 2:63-71.
35. Schmidt MI, Duncan BB, Mill JG, et al. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2014 [Epub ahead of print].
36. Matsuoka M. Contribuição da ultra-sonografia para o diagnóstico das alterações histopatológicas presentes na hepatite C crônica, com ênfase na esteatose hepática [Ultrasonography contribution for the diagnosis of the histopathological alterations in chronic hepatitis C, with emphasis in hepatic steatosis]. [Thesis]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 2008. Available from: http://www.teses.usp.br/teses/disponiveis/5/5151/tde-05082008-142925/ en.php. Accessed in 2014 (Nov 19).
37. Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503-8.
38. Hammerstingl RM, Vogl TJ. Abdominal MDCT: protocols and contrast considerations. Eur Radiol. 2005;15 Suppl 5:E78-90.
39. Alpern MB, Lawson TL, Foley WD, et al. Focal hepatic masses and fatty infiltration detected by enhanced dynamic CT. Radiology. 1986;158(1):45-9.
40. Yajima Y, Narui T, Ishii M, et al. Computed tomography in the diagnosis of fatty liver: total lipid content and computed tomography number. Tohoku J Exp Med. 1982;136(3):337-42.
41. Bydder GM, Chapman RW, Harry D, et al. Computed tomography attenuation values in fatty liver. J Comput Tomogr. 1981;5(1):33-5.
42. Rofsky NM, Fleishaker H. CT and MRI of diffuse liver disease. Semin Ultrasound CT MR. 1995;16(1):16-33.
43. Lee SW, Park SH, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology. 2007;244(2):479-85.
44. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004;230(1):276-80.
45. Foster MC, Hwang SJ, Porter SA, et al. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension. 2011;58(5):784-90.
46. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95.
47. Cumberledge J, Angulo P. Noninvasive prediction of hepatic steatosis. Am J Gastroenterol. 2014;109(9):1415-6.
48. Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. World J Gastroenterol. 2014;20(31):10851-63.